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Vascular networks form, remodel and mature under the influence of multiple signals of
mechanical or chemical nature. How endothelial cells read and interpret these signals,
and how they integrate information when they are exposed to both simultaneously
is poorly understood. Here, we show using flow-induced shear stress and VEGF-
A treatment on endothelial cells in vitro, that the response to the magnitude of a
mechanical stimulus is influenced by the concentration of a chemical stimulus, and
vice versa. By combining different flow levels and different VEGF-A concentrations,
front-rear polarity of endothelial cells against the flow direction was established in
a flow and VEGF-A dose-response while their alignment with the flow displayed a
biphasic response depending on the VEGF-A dose (perpendicular at physiological
dose, aligned at no or pathological dose of VEGF-A). The effect of pharmaceutical
inhibitors demonstrated that while VEGFR2 is essential for both polarity and orientation
establishment in response to flow with and without VEGF-A, different downstream
effectors were engaged depending on the presence of VEGF-A. Thus, Src family
inhibition (c-Src, Yes, Fyn together) impaired alignment and polarity without VEGF-A
while FAK inhibition modified polarity and alignment only when endothelial cells were
exposed to VEGF-A. Studying endothelial cells in the aortas of VEGFR2Y949F mutant
mice and SRCiEC−KO mice confirmed the role of VEGFR2 and specified the role of
c-SRC in vivo. Endothelial cells of VEGFR2Y949F mutant mice lost their polarity and
alignment while endothelial cells from SRCiEC−KO mice only showed reduced polarity.
We propose here that VEGFR2 is a sensor able to integrate chemical and mechanical
information simultaneously and that the underlying pathways and mechanisms activated
will depend on the co-stimulation. Flow alone shifts VEGFR2 signaling toward a Src
family pathway activation and a junctional effect (both in vitro and in vivo) while flow and
VEGF-A together shift VEGFR2 signaling toward focal adhesion activation (in vitro) both
modifying cell responses that govern orientation and polarity.
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INTRODUCTION
During embryonic development, all vertebrates initially establish
a primitive network of vessels that subsequently remodels into
a hierarchical vascular structure. This involves the creation
of a primary vascular plexus that expands by sprouting
angiogenesis (Isogai et al., 2003; Potente et al., 2011) followed
by vascular remodeling to adapt vessel organization, shape
and size; in its course, superfluous and inefficient segments
are pruned away by active regression (Franco et al., 2015).
The cellular and molecular regulation of this process is
influenced by blood flow, hypoxia and metabolism. In this
context, cells need to respond appropriately to both mechanical
and chemical cues to ensure healthy tissue development
and homeostasis.
Endothelial cells (ECs), which constitute the inner layer of
vessels, are in particular under constant mechanical strains
exerted by blood flow. Interestingly, ECs are able to sense
small variations in the direction, magnitude, and regularity of
blood flow–induced shear stress (Wang et al., 2013; Givens and
Tzima, 2016) and respond to such changes by controlling their
number, shape and movement (Culver and Dickinson, 2010;
Baeyens et al., 2016a). Adaptation of ECs to flow is critical
for both the development and the maintenance of a well-
functioning cardiovascular system, as modification of capillary
patterning allows for efficient oxygen and nutrient supply, while
inward and outward remodeling of main arteries maintains
appropriate blood pressure over the entire body (Baeyens et al.,
2015). Physiological shear stress level, as found when the
network is mature will favor EC elongation and orientation
parallel to the flow direction. Furthermore, the Golgi of EC will
position itself upstream of the nucleus, thus pointing against
the flow direction (Franco et al., 2015) indicating their current
migratory direction.
ECs are also well equipped to sense hypoxia. Hypoxic
conditions drive the expression of vascular endothelial growth
factors (VEGFs) by the surrounding tissues, which initiates
endothelial sprouting through binding and activation of VEGF
receptors (VEGFRs). Signaling downstream of these receptors is
essential for vascular morphogenesis, as they control processes
such as EC migration, proliferation and vessel permeability
(Simons et al., 2016) and can influence arterial differentiation
(Carmeliet and Tessier-Lavigne, 2005).
A long-standing question in developmental and cell biology
relates to how cells integrate mechanical and chemical signals
to orchestrate the morphogenic behaviors that ensure adequate
tissue patterning. When looking at the receptors and signaling
cascades implicated in both flow and chemical responses in ECs,
it is clear that they are largely redundant and involve the same
players (Jin et al., 2003; Koch and Claesson-Welsh, 2012). This
suggests a cooperative or competitive action of chemical and
mechanical stimuli during vascular bed formation, patterning,
maturation and maintenance. In this context, VEGFR2 signaling
is one of the most interesting examples. VEGFR2 is essential
for VEGF-A-driven biological effects (Koch et al., 2011). It
becomes activated and phosphorylated on tyrosine residues in
response to VEGF-A: Y951, Y1059, Y1175, and Y1214 (human
sequence numbers) (Matsumoto et al., 2005). The Y951 phospho-
site (Y949 in mouse VEGFR2) presents a specific binding site
for the T cell-specific adaptor which is implicated in VEGF-
A-induced permeability, by regulating VEGFR2-dependent SRC
signaling pathway at EC junctions (Sun et al., 2012). The
Y1059 residues, located on the tyrosine kinase activation
loop, are required for full kinase activity (Koch et al., 2011).
The phosphorylated Y1175 (Y1173 in mouse VEGFR2) binds
phospholipase Cg, which is of importance for endothelial
extracellular-signal-regulated kinase ERK1/2 pathway activation
(Takahashi et al., 2001). A phenylalanine knock-in mouse
Vegfr2Y1173F/Y1173F is embryonically lethal due to an arrest
in EC development (Sakurai et al., 2005). Interestingly this
phosphosite has also been described to be activated by flow,
independently of VEGF, activating ERK1/2 and JNK pathways
as well as eNOS (Chen et al., 1999; Jin et al., 2003). It
has also been shown to activate NFκB both in vitro (Tzima
et al., 2005; Coon et al., 2015) and in vivo (Baeyens et al.,
2015). Finally, VEGFR2 Y1214 signaling induces activation
of ERK1/2 and Akt pathways required for c-Myc-dependent
gene regulation, endothelial proliferation, and vessel stability
(Testini et al., 2019).
MATERIALS AND METHODS
Mice and Treatments
The following mouse strains were used: VEGFRY949F mice
(knock-in of phenylalanine (F) to replace the tyrosine (Y)
at position 949 of VEGFR2 (Li et al., 2016) and c-Src-flox,
Cdh5-CreERT2 mice designated as SRCiEC−KO mice (Cdh5-
CreERT2 mice were provided by Ralf Adams (MPI, Muünster,
Germany) (Kogata et al., 2006; Wang et al., 2010). c-Src-floxed
mice were delivered from the Nice Mice, National Resource
Center for Mutant Mice, Model Animal Research Center,
China) (Schimmel et al., 2020). Mice were maintained at the
Uppsala University under standard husbandry conditions. All
animal work was approved by the Uppsala University board
of animal experimentation (permit 5.2.18-8927-16). To induce
Cre-mediated deletion, tamoxifen (Sigma-Aldrich) was injected
i.p. (100 µg) at P1, P2 and P3. Aortas were then collected
at P6 onward. The investigators were blinded to genotype
during experiments.
Metatarsal Assay
Metatarsals were isolated from E16.5 mice using a protocol
adapted from Song et al. (2015). After dissection, one metatarsal
per well was placed in a µ-Plate 24 well ibiTreat plate with a
1.5 polymer coverslip (Ibidi) and left in 170 µl of MEM-alpha
(Gibco) with 10% FCS and 1% penicillin/streptomycin (Sigma).
After 3 days, media were replaced with 300 µl MEM-alpha + 10%
FCS + 1% pen/strep per well and media changed every 48 h.
To induce Cre activity, cells were treated with 1 µM of 4-
hydroxytamoxifen (Sigma) after 5 days. After 14 days, metatarsals
were fixed in 4% PFA in PBS for 20 min and antibodies were
added in 3% Triton X-100, 1% Tween and 0.5% BSA in PBS.
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The following antibodies were used: GM130 (ref 560066, mouse,
1:500, BD Biosciences), ERG (ref ab92513, rabbit, 1:500, Abcam).
Cell Culture and Microfluidic Chamber
Experiments
HUVECs (passage 2–6; PromoCell) were routinely cultured in
EBM-Bulletkit (Promocell). For flow experiments including static
condition leading to WB lysate collection or immunofluorescence
from Figures 2, 3, cells were cultured on 0.2% gelatin-coated
slides (Menzel Glazer) and unidirectional laminar shear stress
was applied using peristaltic pumps (Gilson) connected to a glass
reservoir (ELLIPSE) and the chamber containing the slide. This
device allows the circulation of 10 ml of medium on the slides,
static slides has been exposed to 10 ml of medium without any
medium circulation. For flow experiments under high shear stress
(Figure 4) and immunofluorescence staining, cells were cultured
on 0.2% gelatin-coated 0.4 ibidi slides (IBIDI) and unidirectional
laminar shear stress was applied using the pumping system and
control unit form IBIDI, allowing the circulation of 10 ml of
medium as for the peristaltic system.
Local shear stress was calculated using Poiseuille’s law and
averaged to 2 (Low SS) or 20 dyn/cm2 (High SS). For VEGF-
A treatment, cells were exposed to shear stress for 24 h using
EBM media (Promocell) without VEGF-A supplement and co-
stimulated with 0, 0.5, 10 or 200, ng/ml of human VEGF-A165
(PeproTech ref 450-32) under the different flow conditions.
For inhibition experiments, VEGFR2 inhibitors (SU1498, 1.5
µM; ZM323881, 4 nM), Src family inhibitor (SU6656, 500 nM),
FAK inhibitor (PND-1186, 3 nM) and p38 inhibitor (SB203580,
1 µM) were added to the media 30 min prior flow start.
Control condition were treated with DMSO diluted at 1/1,000 as
all inhibitor used.
Western Blotting
HUVECs were washed with cold PBS and scraped off in
M-PER (Mammalian Protein Extraction Reagent; Thermo
Fisher Scientific) completed protease and phosphatase inhibitors
(Roche). Lysates were centrifuged and protein supernatant was
quantified using the Lowry protein assay (Bio-Rad). Lysates
were mixed with reducing sample buffer for electrophoresis
and subsequently transferred onto polyvinylidene fluoride
membranes. Equal loading was checked using Ponceau red
solution. Membranes were incubated with primary antibodies
(see below). After incubation with secondary antibodies (1:3,000;
GE Healthcare), immunodetection was performed using an
enhanced chemiluminescence kit (SuperSignal West Dura;
Pierce), and bands were revealed using the Las-4000 imaging
system. After initial immunodetection, membranes were stripped
of antibodies, probed with total form of the phosphorylated
form when suitable (PXL) and then reprobed with anti–GAPDH
antibody. Values reported from Western blots were obtained
by band density analysis using FIJI (ImageJ) and expressed
as the ratio of the protein of interest to GAPDH or as the
ratio of phosphorylated form to total form of the protein
of interest. The following antibodies were used: GAPDH (ref
MAB374, goat; 1:10,000; Millipore), VEGFR2 (ref 2479, rabbit,
1:1,000; cell signaling), p1175-VEGFR2 (ref 3770, rabbit, 1:1,000;
cell signaling), p951-VEGFR2 (ref 2471, rabbit, 1:1,000; cell
signaling), VE-cadherin (ref ab33168, rabbit, 1:1,000; abcam),
p685-VE-cadherin (ref ab119785, rabbit, 1:1,000; abcam), ZO-
1(ref 61-7300, rabbit, 1:1,000; Thermo Fisher Scientific), FAK
(ref 3285, rabbit, 1:1,000; cell signaling), Claudin5 (ref 34-
1600, rabbit, 1:1,000; Invitrogen), Paxillin (ref 610051, rabbit,
1:1,000; BD Biosciences), p118-Paxillin (ref 2541, rabbit, 1:1,000;
cell signaling).
Immunofluorescence Staining
HUVECs were fixed with 4% PFA in PBS for 10 min at room
temperature (RT). Blocking/permeabilization was performed
using blocking buffer consisting of 5% BSA (Sigma-Aldrich),
0.5% Triton X-100 (Sigma-Aldrich), 0.01% sodium deoxycholate
(Sigma-Aldrich), and 0.02% sodium azide (Sigma-Aldrich) in
PBS at pH 7.4 for 45 min at RT. Primary antibodies were
incubated at the desired concentration in 1:1 Blocking buffer/PBS
at RT for 2 h and secondary antibodies were incubated at the
desired concentration in 1:1 blocking buffer/PBS for 1 h at
RT. Aortas were fixed with 4% PFA in PBS overnight at 4◦C.
Blocking/permeabilization was performed using blocking buffer
consisting of 1% FBS, 3% BSA (Sigma-Aldrich), 0.5% Triton
X-100 (Sigma-Aldrich), 0.01% sodium deoxycholate (Sigma-
Aldrich), and 0.02% sodium azide (Sigma-Aldrich) in PBS at pH
7.4 for 1 h at RT. Primary antibodies were incubated at the desired
concentration in 1:1 Blocking buffer/PBS overnight at 4◦C and
secondary antibodies were incubated at the desired concentration
in 1:1 blocking buffer/PBS for 2 h at RT. DAPI (Sigma-Aldrich,
1/10,000, 5 min) was used for nuclear labeling. Cells and aortas
were mounted in Mowiol. The following antibodies were used
in vitro: VE-cadherin (ref sc-6458, goat; 1:100; Santa cruz), ZO-
1 (ref 61-7300, rabbit, 1:500; Thermo Fisher Scientific), GM130
(ref 610822, mouse, 1:1,000;BD Biosciences). The following
antibodies were used in vivo: GOLPH4 (ref ab28049, rabbit; 1:500;
Abcam), VE–cadherin (ref 555289; rat; 1/100; BD Biosciences).
Microscope Image Acquisition
Images from fluorescently labeled HUVECs were acquired
using a LSM 700 upright microscope equipped with a Plan-
Apochromat 20×/0.8 NA Ph2 objective. Images were taken at
room temperature using Zen 2.3 software. Bright-field images
were taken using a Leica DMIL LED microscope equipped with
a 10×/0.22 NA Ph1 objective and a CCD camera (DFC3000 G).
Images were acquired at room temperature while the cells were
still in their culture medium using LAS X software (Leica). Images
of aortas were taken using a LSM 780 inverted microscope (Zeiss)
equipped with a Plan-Apochromat 20×/0.8 NA Ph2 objective
or with a Plan-Apochromat 63×/1.4 NA DIC objective. The
microscope was equipped with a photon multiplier tube detector.
Images were taken at room temperature using Zen 2.3 software
(Zeiss). Images of metatarsals were acquired using a LSM 710
inverted microscope equipped with Plan-Apochromat 10×/0.45
NA and 20×/0.8 NA objectives. For all animal experiments, the
investigators were unaware of the genotypes of the animals while
acquiring images.
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Cell Junction Activity Analysis
Cell junction morphology analysis was done in HUVECs stained
for VE-cadherin using the patch and classified Matlab code
previously developed by Bentley et al. (2014) adapted for 2D
images. Two status were defined: activated vs. stabilized, and
divided into 3 level: from low to high. Activated junctions were
defined as serrated or reticular and stabilized as straight thick
junctions. Each image taken was divided into small pieces of
images allowing to visualized only a portion of the junction
and these small images were presented blindly and randomly
to the user who then classified the junction accordingly. This
technic ensured an unbiased analysis of the junctions regarding
the treatment and regarding the global shape of the cell.
Flow-Induced Orientation Analysis
To analyze the orientation of cells, we calculated the angle formed
between the vector of the flow direction (obtained by knowledge
of flow direction within the slide) and the “orientation vector”
given by orientation of the main axe of each cell. Each value
for each cell is then used to plot the hemi-roses presented in
Figure 2A. To plot the bar graphs presented in Figures 2B,
4B, 5B, 6B the cells were classified in 2 categories: aligned with
the flow direction, and not aligned with the flow direction. For
in vitro experiment, aligned with the flow was defined as an
absolute value of angle between 0 and 45◦, not aligned with
the flow as an absolute value of angle between 45 and 90◦; for
in vivo experiments, aligned with the flow was defined as an
absolute value of angle between 0 and 15◦ and not aligned with
the flow as an absolute value of angle between 15 and 90◦. Angle
calculation and roses presentation was done automatically using
a homemade Matlab script validated on the first experiment by a
comparison to hand calculation with FIJI.
Flow-Induced Polarity Analysis
To analyze the polarization of cells, we calculated the angle
formed between the vector of the flow direction (obtained by
knowledge of flow direction within the slide) and the “golgi
vector” given by the line from the center of the nucleus to the
center of the Golgi. Of note, static experiments are not exposed
to flow and therefor calculation has been made using an arbitrary
direction given by the geometry of the ibidi slide. Each value for
each cell is then used to plot the roses presented in Figure 2C. To
plot the bar graphs presented in Figures 2D, 4D, 5D, 6D, the cells
were classified in 3 categories: against the flow direction, sided
to the flow direction and with the flow direction. For in vitro
experiment, with the flow was defined as an absolute value of
angle between 0 and 45◦, sided as an absolute value of angle
between 45 and 135◦ and against the flow as an absolute value
of angle between 135 and 180◦; for in vivo experiment with the
flow was defined as an absolute value of angle between 0 and
30◦, sided as an absolute value of angle between 30 and 150◦
and against the flow as an absolute value of angle between 150
and 180◦. Angle calculation and roses presentation was done
automatically using a homemade Matlab script validated on the
first experiment by a comparison to hand calculation with FIJI.
Metatarsal polarity analysis was performed using FIJI with values
defined as for in vivo experimental values (with: 0–30◦, sided:
30–150◦, and against: 150–180◦).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
software. For in vitro and in vivo experiments, two-way ANOVA
(data distribution was assumed to be normal) were used, followed
by a Tukey test or a Fisher LSD test when conditions were
considered experimentally independent. Details of the statistical
test used for each experiment can be found in the figure legends.
The investigators were blinded to genotype during experiments
and quantification.
EXPERIMENTAL APPROACH
To study how physical forces and growth factors jointly
influence front-rear polarity and cell elongation toward the flow
direction (alignment/orientation), we subjected ECs to either
static conditions, low or high shear stress (SS, 2 or 20 dyn/cm2
for 24 h) and to different VEGF-A concentrations ranging from
physiological (0.5 and 10 ng/mL) to pathological (200 ng/mL)
levels. Cell orientation refers to the long axis of ECs as they
adopt their prototypical elongated cell shape under the influence
of blood flow in vivo, or equivalent shear stress induced by
medium flow in vitro. Alignment in this context depicts whether
this long-axis of the ECs is aligned with the direction of the
flow. Similarly, front-rear polarity is also assessed in relation to
the flow direction. Unlike elongation or alignment, the polarity
vector assigns a front and a rear to the cell, in a way that is
normally associated with dynamic movement of cells in a certain
direction. When they migrate, many cell types, including ECs,
position their centrosome and Golgi ahead of the nucleus in
the direction of migration. Therefore, determining the center of
mass of the Golgi in relation to the center of mass of the cell
nucleus delivers a vector that can be used as a proxy for front-
rear polarity of migrating cells. Recent work illustrated that ECs
under flow in vivo and in vitro follow the same principle as
they orientate and migrate against the direction of flow during
vascular remodeling (Kupfer et al., 1982; Franco et al., 2015).
We therefore determined the Golgi-nucleus vector to establish
front-rear polarity under all conditions of SS and growth factor
stimulation. Throughout the analysis below, cell alignment and
polarity in relation to the direction of flow will serve as reference
system for the phenotypical flow response of ECs (Figure 1).
As the polarized movement of ECs requires junctional
rearrangements and turnover, both during angiogenic sprouting
and vascular remodeling under flow (Koch et al., 2011;
Conway et al., 2013; Neto et al., 2018), we also assessed
endothelial junctional patterns under the various conditions.
Previous studies classified junctional features that correlate
with junctional dynamics and VE-cadherin turnover (Bentley
et al., 2014), providing a useful quantitative framework for
the assessment of flow and growth factor effects. We used
this classification tool adapted for a 2D layer to evaluate
junctional activity in our different in vitro conditions. We
complemented these results with biochemical analysis of VE-
cadherin phosphorylation on Tyrosine 685, which contributes
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FIGURE 1 | Experimental approach. In vitro, We subjected ECs to either static condition, low or high shear stress (SS, 2 or 20 dyn/cm2 for 24 h) and to different
VEGF-A concentrations ranging from physiological (0.5 and 10ng/mL) to pathological (200 ng/mL) levels. In vivo, we used the linear part of aorta which is exposed to
high SS and free from VEGF-A influence. Phenotypical response: Cell orientation/alignment refers to the long axis of ECs as they adopt their prototypical
elongated cell shape under the influence of blood flow in vivo, or equivalent shear stress induced by medium’s flow in vitro. Determining the center of mass of the
golgi in relation to the center of mass of the cell nucleus delivers a vector used as a proxy for front-rear polarity of migrating cells. Functional response: biochemical
analysis of VEGFR2 phosphorylation on Tyrosine 1175 and 951; VE-cadherin phosphorylation on Tyrosine 685; Paxillin phosphorylation on Tyrosine 118.
classification of junction type through VE-cadherin staining. Pathways: inhibition through drug treatment (in vitro) or Knock-Out strategies (in vivo) and analysis of the
phenotypical response.
to VE-cadherin internalization (Orsenigo et al., 2012). Since
VEGFR2 is a flow sensor (Tzima et al., 2005) when associated to
PECAM and VE-cadherin, in addition to its VEGF-A receptor
activity, we then employed biochemical analysis to study its
activation. We exposed ECs to selective inhibitor treatments
to identify pathway activity patterns and their relevance for
the different aspects of the endothelial phenotypical response
to flow. Finally, we validated our results using an in vivo
approach. The aorta is exposed to high SS (similar level as
used in our in vitro experiments) in its linear, thoracic part
and free from VEGF-A influence. In this model, ECs forming
the linear part are highly elongated and aligned with the flow
direction and mostly polarized against the flow. In contrast
EC display rounded shape and random alignment in the aortic
arch exposed to turbulent flow generating low SS (Gimbrone
and García-Cardeña, 2013). We took advantage of these aortic
characteristics to assess EC alignment in deficient mice models
to validate our in vitro finding on phenotypical response to
flow (Figure 1).
RESULTS
Combination of Flow Exposure and
VEGF-A Treatment Modifies Endothelial
Cell Orientation and Polarity
As VEGF-A induces proliferation of ECs (Koch et al., 2011), we
first controlled whether our experimental condition influenced
cell density and therefore the analyses. In all conditions,
static, low SS (2 dyn/cm2), or high SS (20 dyn/cm2),
VEGF-A (0.5–200 ng/ml) did not affect the EC number
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FIGURE 2 | Dose-dependent effect of shear stress and VEGF-A concentration on cell orientation and polarity. (A) Representative picture (phase contrast) of
endothelial cells exposed to shear stress for 24 h (static: 0 dyn/cm2; Low SS: 3 dyn/cm2; High SS: 20 dyn/cm2) and associated orientation quantification shown as
circular plots (N = 3; between 1,500 and 3,000 cells analyzed). (B) Quantification of percentage of cells aligned with the flow direction (in between 45◦ around the
flow axis, N = 3, between 1,500 and 3,000 cells analyzed), Data presented as Mean + SEM. (C) Representative picture (Immunofluorescence) of endothelial cells
exposed to shear stress for 24 h (Low SS: 3 dyn/cm2; High SS: 20 dyn/cm2) (scale bars: 30 µm). (D) Quantification of golgi position around the nucleus compared
to the flow direction (N = 3; with: in between 0 and 45◦ around the flow axis, side: 45–135◦, against: 135–180◦; between 1,500 and 3,000 cells analyzed). Two-way
ANOVA; Tukey’s post hoc, *p < 0.05; **p < 0.01; ***p < 0.001.
(Supplementary Figure 1A). Both high and low SS exposure
reduced the number of cells to about 75% of that in the static
conditions. Alignment analyses showed that the ECs main axis in
static condition (no flow, 0 dyn/cm2) was randomly distributed,
with no effect of VEGF-A addition (Figures 2A,B). The only
effect observed was an increase in cell elongation after treating
ECs with 200 ng/mL of VEGF-A (Supplementary Figure 1B).
Low SS (2 dyn/cm2, no VEGF-A) had no effect on cell
alignment, which remained random. VEGF-A addition (0.5
ng/ml) to low SS promoted alignment perpendicular to the flow
direction while treatment with 200 ng/ml VEGF-A promoted
EC alignment with the flow (Figures 2A,B). This showed that
the effect of VEGF-A under low SS was biphasic, dependent
on the dose used.
High SS itself (20 dyn/cm2, no VEGF-A) enhanced alignment
with the flow. VEGF-A addition (0.5 ng/ml) to high SS made
ECs align perpendicular to the flow direction. At high VEGF-
A concentrations (200 ng/ml), alignment with the flow was
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FIGURE 3 | Effect of flow and VEGF-A combination on VEGFR2, junctional and focal adhesion activity. (A) Representative picture (Immunofluorescence) of
endothelial cells exposed to shear stress for 24 h (Low SS: 3 dyn/cm2; High SS: 20 dyn/cm2). Red arrows indicate gaps in the ECs monolayer (B) Quantification of
junction status based on their morphology (N = 3; 100 patches analyzed blinded by images, 5–8 images per N) (scale bars: 20 µm, same magnification for all
images). (C) WB analysis of VE-cadherin phosphorylation, N = 5, (D) WB analysis of VEGFR2 phosphorylation on Tyr951. N = 4 (E) WB analysis of VEGFR2
phosphorylation on Tyr1175. N = 4 (F) WB analysis of Paxilllin phosphorylation on Tyr118. N = 4 (G) WB representative images. Data presented as Mean + SEM.
Two-way ANOVA; Fisher LSD test, *p < 0.05; **p < 0.01; ***p < 0.001 compared to static 0 VEGF; ##p < 0.01; ###p < 0.001 (compared to LSS 0 VEGF);
!!p < 0.01 (compared to HSS 0 VEGF); $$p < 0.01; $$$p < 0.001 compared to static from the same VEGF concentration; ∧∧p < 0.05; ∧∧∧p < 0.01 compared to
Low SS from the same VEGF concentration.
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FIGURE 4 | Pathways involved in flow and VEGF responses. (A) Representative picture of junction (VE-cadherin mentioned as VE-cadh) of endothelial cells exposed
to shear stress for 24 h (High SS: 20 dyn/cm2) without or with inhibitors (scale bars: 40 µm, same magnification for all images). (B) Quantification of percentage of
cells aligned with the flow direction (in between 30◦ around the flow axis. DMSO, N = 5, inhibitors N = 3). (C) Representative picture polarity of endothelial cells
exposed to shear stress for 24 h (High SS: 20 dyn/cm2) without or with inhibitors (scale bars: 40 µm, same magnification for all images). (D) Quantification of golgi
position around the nucleus compared to the flow direction (DMSO, N = 5, inhibitors N = 3. with: in between 0 and 45◦ around the flow axis, side: 45–135◦, against:
135–180◦). Arrow represents flow direction (High SS). Two-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. VEGFR2 inhibitors (SU1498, 1.5 mM; ZM323881,
4 nM), Src family inhibitor (SU6656, 500 nM), FAK inhibitor (PND-1186, 3 nM) and p38 inhibitor (SB203580, 1 mM) were added to the media 30 min prior flow start.
Frontiers in Physiology | www.frontiersin.org 8 March 2021 | Volume 11 | Article 623769
fphys-11-623769 February 24, 2021 Time: 17:6 # 9
Vion et al. Endothelial Responses to Flow and VEGF
increased, as observed under low SS (Figures 2A,B) but even
more pronounced.
When assessing polarity, ECs in static culture remained
randomly polarized in the absence and presence of VEGF-A
(Figures 2C,D). At low SS in the absence of VEGF-A, ECs
polarized in the direction “with” the flow, meaning that their
Golgi was mostly placed behind the nucleus compared to the flow
direction. On the contrary, high SS triggered a partial polarization
against the flow. In both low and high SS, VEGF-A promoted
polarity against the flow, in a dose-response manner: the higher
the VEGF-A concentration, the better cells polarized against the
flow (Figures 2C,D).
Taken together, these data show that ECs align and orient
themselves relative to flow by integrating chemical and flow
conditions and that the magnitude of the stimuli direct the
response. With the more pronounced combined stimulation, ECs
aligned efficiently and polarized against the flow.
Combination of Flow Exposure and
VEGF-A Treatment Affects VEGFR2
Phosphorylation, Adherens Junction
Stability and Focal Adhesion Activity
We then looked at cell adherens junctions. Under static
conditions, VE-cadherin staining and quantification of stabilized
(straight) and activated (serrated) junctions did not show
any effect of VEGF-A treatment after 24 h (Supplementary
Figures 2A,B). ZO-1 appeared localized at the junction
for all VEGF-A concentration (Supplementary Figure 2A).
Some discontinuities in the adherens junctions were observed
at 200 ng/mL (Supplementary Figure 2, red arrow). This
was not associated to a change in VE-cadherin and ZO-1
protein levels upon SS and VEGF-A exposure (Supplementary
Figures 3B,C).
Upon low SS alone (no VEGF-A), ECs showed a high level of
activated/serrated junctions (Figures 3A,B). VEGF-A treatment
had no additional effect on junction activation which remained
high. In contrast, high SS induced stabilization/straightening
of the junctions and increasing the concentration of VEGF-A
correlated with an increase in serrated VE-cadherin junctions
(Figures 3A,B). Junctional ZO-1 was higher in ECs exposed to
high SS than in ECs exposed to low SS (Figure 3A). VEGF-
A treatment induced a loss of this junctional ZO-1 both under
low and high SS (Figure 2A). Additionally, both under low and
high SS, high VEGF-A concentrations (10 and 200 ng/mL) led to
loosening of the adherens junctions, which displayed increased
number of gaps in the endothelial layer (indicated as red arrows
on Figure 3A), to a higher extent at high SS.
To better understand the junctional modifications, we
analyzed VE-cadherin phosphorylation on Tyrosine 685, which
contributes to VE-cadherin internalization (Orsenigo et al.,
2012). Under static condition, VEGF-A treatment increased
VEcadhY685 level in a dose dependent manner (Figures 3C,G).
ECs exposed to low SS have high VE-cadherin phosphorylation
level independently of VEGF-A concentration (Figures 3C,G),
matching the observation of high level of serrated junction in this
flow condition. VEcadhY685 levels remained low under high SS
independently of VEGF-A concentration and despite increasing
serrated junctions.
Since VEGFR2 is a flow sensor (Tzima et al., 2005) when
associated to PECAM and VE-cadherin in addition to its
VEGF-A receptor activity, we evaluated its phosphorylation
status in our conditions. First, we confirmed that both
tyrosine 1175 and 951 were phosphorylated in a dose-response
manner upon VEGF-A treatment under static conditions
(Figures 3D,E,G). VEGFR2 expression was stable in static
condition but significantly increased in response to flow in
the absence of VEGF-A (Supplementary Figure 3A). Of note,
high VEGF-A treatment (200 ng/mL) slightly but significantly
decreased VEGFR2 expression, suggesting modification in
protein turn over. VEGFR2Y1175 phosphorylation level was
increased by SS (Figures 3E,G) in the absence of VEGF-A, with
high SS inducing more VEGFR2Y1175 phosphorylation than low
SS. In comparison, VEGFR2Y951 phosphorylation was increased
by SS but at an equivalent level between low and high SS
(Figures 3D,G). When ECs were exposed to low SS, VEGF-
A treatment strongly increased VEGFR2Y951 and VEGFR2Y1175
phosphorylation in a dose-response manner while this effect was
not present (VEGFR2Y951) or mild (VEGFR2Y1175) when ECs
were exposed to high SS (Figures 3D,G).
As VEGFR2 activation can also affect focal adhesion formation
(Pietilä et al., 2019), we then checked the expression levels
of FAK and Paxillin and the phosphorylation level of Paxillin
on tyrosine 118, which controls focal adhesion turn over,
affinity to FAK and cell migration (López-Colomé et al., 2017).
FAK and Paxillin displayed stable expression over all of the
tested conditions (Figure 3F and Supplementary Figure 3F).
PaxillinY118 phosphorylation was activated by both low and high
SS in the absence of VEGF-A compared to static condition
(Figures 3F,G). At low SS, increasing VEGF-A concentration
did not significantly change PaxillinY118 phosphorylation level.
In contrast, at high SS, VEGF-A treatment increased it in a
dose-response manner (Figures 3F,G).
Combined, these data show that low flow induced an
“activated” junctional morphology and phosphorylation of
VEGFR2 and VE-cadherin; these effects were further augmented
by VEGF-A. In contrast, high flow combined with VEGF-A
preferentially induced focal adhesion signaling.
VEGFR2 Is Involved in Orientation and
Polarity Responses Through Different
Signaling Cascades
In order to understand better how activation of VEGFR2
contributed to focal adhesion or adherens junction turn-
over in our setting and what was the role of each one
in orientation and polarity, respectively, we exposed ECs
to pharmacological inhibitors targeting the known pathways
downstream of VEGFR2 activation. We decided to focus on the
condition that displayed the clearest dichotomic effects of flow
and VEGF-A on polarity and alignment respectively, namely high
SS with or without 10 ng/mL of VEGF-A.
VEGFR2 inhibition by SU1498 and ZM323881 (two different
kinases inhibitor with a high selectivity for VEGFR2 but targeting
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different downstream effectors) had a strong effect on cell
elongation and alignment with the flow in absence of VEGF-
A; ECs were less elongated (Supplementary Figure 4) and
lost their alignment with the flow (Figures 4A,B). Surprisingly,
SU1498 had no significant effect on cell alignment and elongation
in presence of VEGF-A (Figures 4A,B and Supplementary
Figure 4) and ZM323881 tended to restore alignment with the
flow in presence of VEGF-A. VEGFR2 inhibition also impaired
ECs polarization against the flow both without (SU1498) and with
VEGF-A (ZM323881) (Figures 4C,D).
We then inhibited SRC family kinases members (SU6656),
FAK (PND-1186) and p38 (SB203580) in order to target pathways
responsible for ECs cellular processes implicated in adhesion and
migration. SRC family kinases inhibition significantly reduced
ECs alignment with the flow and polarity against the flow in
the absence of VEGF-A but had no effect in presence of VEGF-
A. In contrast, FAK inhibition significantly impaired alignment
with the flow and polarity against the flow only when ECs were
exposed to VEGF-A (Figures 3A–D) but not when VEGF-A
was absent. This demonstrated that cell orientation and polarity
were under the control of different pathways in the presence
or absence of VEGF-A. Interestingly, p38 inhibition which
prevents stress activation and migration of ECs, blocked EC
alignment and elongation both with and without VEGF-A, but
had no effect on cell polarity; ECs remained partially polarized
against the flow as in control condition (Figures 4A–D and
Supplementary Figure 4).
These data support the notion that alignment in response to
flow is dependent on VEGFR2 and that alignment and polarity
are differently regulated by pathways downstream of VEGFR2.
VEGFR2 and SRC Control Endothelial
Cell Orientation and Polarity in vivo in
Matures Arteries
As SRC family kinases inhibition impaired ECs response to flow
in the absence of VEGF-A in vitro, we evaluated the relevance
of the VEGFR2—SRC pathway in vivo. First, As VEGFR2-949
phosphorylation by VEGF stimulation recruits activated Src
to EC junctions to phosphorylate VE-cadherin, we analyzed
the aortas of VEGFR2Y949F mutant mice. We observed that
ECs from the aorta of VEGFR2Y949F mutant mice lost their
alignment in response to flow (Figure 5A) and had a reduced
cell length (Supplementary Figures 5A,B), similar to what
we observed in vitro following treatment with the VEGFR2
inhibitor ZM323881 (Supplementary Figure 4). Loss of VEGFR2
phosphorylation on this specific site also impaired polarity of ECs
against the flow; the proportion of ECs well polarized against the
flow was decreased compared to control mice (Figure 5C). To
study whether this effect was associated specifically with SRC and
not YES or FYN in vivo, we assessed alignment and polarity of
ECs in aortas of mice lacking endothelial SRC (SRCiEC−KO mice).
Cell shape and junction morphology was similarly affected
in SRCiEC−KO aortas as in VEGFR2Y949Faortas. Surprisingly,
however, EC alignment with the flow was not impaired in
SRCiEC−KO aortas (Figures 6A,B) nor was there any effect on
EC length (Supplementary Figure 5B). Nevertheless, polarity
against the flow was reduced in SRCiEC−KO mice compared to
control (Figures 6C,D) similarly to VEGFR2Y949F mutant mice.
Finally, to confirm the flow specificity of these observations,
we used an ex vivo sprouting assay from mouse metatarsals
(Song et al., 2015; Schimmel et al., 2020), which reproduced
angiogenesis in a “no flow” but high growth factor condition.
Polarity of ECs at the tip position was not altered in metatarsal
explants from SRCiEC−KO mice compared to control mice
(Supplementary Figure 6). These results indicate that SRC
activity is not generally required for ECs to polarize, but
selectively involved in flow induced cell polarity.
In conclusion, the in vitro and in vivo data agree on the
importance of VEGFR2, specifically through pY951 signaling,
in endothelial cell alignment and polarity. Moreover, the Src
pathway regulates polarity but not alignment of ECs.
DISCUSSION
In the past decade, many efforts have been made to elucidate how
mechanical forces and chemical signals contribute to vascular
formation and patterning. Several mechano-sensory pathways
controlling cell shape (Levesque and Nerem, 1985; Wojciak-
Stothard and Ridley, 2003; Noria et al., 2004), polarity (Franco
et al., 2015; Kwon et al., 2016) and migration (Baeyens et al.,
2016b; Rochon et al., 2016) during vascular patterning have
been described and the basic cellular and molecular mechanisms
controlling angiogenesis have been well characterized (Potente
et al., 2011; Potente and Mäkinen, 2017). Nevertheless, how ECs
integrate signals coming from both mechanical and chemical
stimuli at the same time is not well understood, despite its
importance in physiology and pathology. Here, we observed
that these signals can have synergistic or antagonistic effects
depending on the feature observed.
We first confirm that VEGF-A treatment increases cell
elongation, VEGFR2Y1175, VEGFR2Y951 and VEcadhY685
phosphorylation levels in a dose dependent manner under static
condition, as expected from the literature (Simons et al., 2016;
Cao et al., 2017). We also observe already described effects
of low SS and high SS on cell alignment (Chien, 2007; Wang
et al., 2013), junctions aspect (Chiu and Chien, 2011) and
changes in VEGFR2Y1175 phosphorylation (Jin et al., 2003) in
the absence of VEGF-A. However, beyond these observations,
we also identify new features associated with the combination
of flow and VEGF-A. Polarity against the flow is established
in a dose-response to VEGF-A both under low and high SS,
but only high SS could trigger polarity against the flow without
VEGF-A. Furthermore, alignment displays a biphasic response
depending on the VEGF-A level (aligned without VEGF or
at pathologically high dose of VEGF-A, but perpendicular to
flow at physiological levels of VEGF-A). This indicates that
orientation and polarity are controlled by different mechanisms.
Interestingly, the effect of VEGF-A on polarity under high SS was
seen even from the lowest concentrations used (0.5 ng/mL) while
a higher concentration (10 ng/ml) was required to reach the same
percentage of polarity against the flow at low SS. This suggests
that both parameters mutually control the cells’ sensitivity to
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FIGURE 5 | VEGFR2 mutation impaired cell orientation and cell polarity in vivo. (A) Representative images of VE-cadherin staining of endothelial cell from the aortas
of littermate P6 pups (CTR) or carrying VEGFR2 mutation (Y949F) (scale bars: 25 and 10 µm, respectively). (B) Quantification of cells aligned with the flow direction
(in between 15◦ around the flow axe, N = 5, Data presented as Mean + SEM. (C) Representative images of golgi staining of endothelial cell from the aortas of P6
pups littermate (CTR) or carrying VEGFR2 mutation (Y949F) (scale bars: 25 µm). (D) Quantification of golgi position around the nucleus compared to the flow
direction (N = 5; with: in between 0 and 30◦ around the flow axe, side: 30–150◦, against: 150–180◦). Two-way ANOVA; Tukey’s post hoc, *p < 0.05; ***p < 0.001.
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FIGURE 6 | SRC deletion in ECs mutation impaired cell orientation and cell polarity in vivo. (A) Representative images of VE-cadherin staining of endothelial cell from
the aortas of P6 pups littermate (CTR) or deleted for SRC in ECs (SRCiEC-KO) (scale bars: 25 and 10 µm, respectively). (B) Quantification of cells aligned with the
flow direction (in between 15◦ around the flow axe, WT, N = 6; KO, N = 7, Data presented as Mean + SEM. (C) Representative images of golgi staining of endothelial
cell from the aortas of P6 pups littermate (CTR) or deleted for SRC in ECs (SRCiEC-KO) (scale bars: 25 µm). (D) Quantification of golgi position around the nucleus
compared to the flow direction (WT, N = 6; KO, N = 7; with: in between 0 and 30◦ around the flow axe, side: 30–150◦, against: 150–180◦). Two-way ANOVA; Tukey’s
post hoc, *p < 0.05; ***p < 0.001.
the other. Shear Stress modifies the sensitivity to VEGF-A, but
VEGF-A in turn also affect the cell’s ability to respond to flow.
When inhibiting VEGFR2, the effects of both SS and VEGF-A
on alignment and polarity are lost suggesting that VEGFR2 could
be the hub controlling these responses. The effect of SU1498 on
polarity was significant only in the absence of VEGF-A, whereas
ZM323881 significantly affected polarity only with VEGF-A.
Studies using these inhibitors highlight their selectivity for
VEGFR2 but also show that SU1498 prevents ERK1/2 signaling
cascade (Boguslawski et al., 2004) while ZM323881 inhibits rather
p38 and Rac1 pathways (Whittles et al., 2002; Garrett et al., 2007).
Altogether this suggests that these inhibitors might differently
restrict pathways downstream of VEGFR2 that contribute to
polarity establishment with or without VEGF-A.
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Inhibiting downstream effectors of VEGFR2, namely FAK and
SRC family members, uncovered that the orientation and polarity
of ECs are controlled differently in the presence or absence of
VEGF-A. Without VEGF-A, alignment with the flow and polarity
against the flow are dependent on SRC family activity while in
the presence of VEGF-A, alignment and polarity against the flow
are dependent on FAK activity. Interestingly, p38 inhibition only
impaired alignment with the flow, not polarity which remains
mostly against the flow. In this context, p38 inhibition suggests
that ECs can establish and modify their planar polarity without
changing their cell shape.
These conclusions are further supported by our in vivo
analysis, as VEGFR2 phosphorylation at Y951 contributes to ECs
alignment with the flow and polarity against the flow in the
absence of VEGF-A. By genetically deleting SRC specifically in
ECs, we highlight that SRC is essential for polarity control but
not for alignment, although this was expected from our inhibitor
experiments in vitro. Interestingly, the inhibitor used in vitro has
a strong affinity toward Yes and Fyn, the two other SRC family
members. While Yes and Fyn are structurally highly similar to
SRC, evidence for their distinct roles in the endothelium are
currently emerging (Eliceiri et al., 1999; Gordon et al., 2016;
Schimmel et al., 2020). Combining our in vivo and in vitro results,
we can propose that loss of SRC impairs endothelial polarity
against the flow, which is not compensated by Fyn or Yes. Loss of
SRC had no effect on ECs alignment in vivo suggesting that this
feature could be under the control of Yes or Fyn. Further work
will need to establish the exact contribution of Yes and Fyn to the
alignment of ECs in response to flow. In the same line as for the
p38 inhibition in vitro, we highlight that polarity and alignment
can occur independently, but here showing that change in cell
shape does not required planar polarity establishment.
By pointing their Golgi better against the flow at high SS,
ECs display a cellular organization that is characteristic for
their migration against the flow. In both SS conditions, VEGF-
A will cause an activation that will enable ECs to adjust their
junctions and basal adhesions more dynamically and polarize
better against the flow even if exposed to a lower unidirectional
force. Whether polarity always correlates with cell displacement
(migration), however, remains unclear. Two hypotheses arise
from the increased polarity against the flow; the first one is that
ECs are indeed migrating better against the flow at high SS or with
VEGF-A addition, the second would be that while ECs polarize
against the flow at high SS or with VEGF-A, they migrate very
little due to high counteracting apical forces.
Both hypotheses raise the question of tension sensing and
balance between basal and lateral forces. Force transmission
occurs through different structures in ECs (Campinho et al.,
2020; Gordon et al., 2020); cell-cell junctions and cell adhesions
to the matrix have been both well described as mechano-
sensitive elements. In our study, the structural changes of
VE-cadherin junctions do not correlate with alteration of
VEcadhY685 phosphorylation, suggesting that other junctional
players are involved. Interestingly ZO-1 has been shown to
control endothelial cell-cell tension and its loss, while loosening
tension in-between cells favors focal adhesion formation
(Tornavaca et al., 2015) and therefore reinforces basal adhesion.
In our setting, ZO-1 localization at junctions is specifically
decreased by VEGF-A when ECs are exposed to SS compared
to static condition and could be the missing player explaining
the visual modifications of adherens junctions. Additionally,
increased Paxillin phosphorylation also correlates with the loss
of junctional ZO-1. Together with our observation, this supports
our hypothesis that tension forces in between ECs could be highly
different in between our different in vitro conditions. VEGF-A
addition under SS, would trigger loss of cell-cell tension (lateral)
while increasing cell-matrix tension (basal). This effect of VEGF-
A appears to be more pronounced at high SS compared to low SS.
Another situation where ECs adapt their shape and polarity
is when they migrate to close a wound. In such a case, driven
by the first row of cells directly in contact with the free edge,
ECs polarize collectively and migrate toward the wound. In that
situation, the origin of the signal is different from a flow situation.
In a wound assay, most cells are not exposed to the free edge and
receive an indirect cue for migration through force transmission
via the lateral junctions. Recent work from Carvalho et al. (2019)
shows that by decreasing VE-cadherin tension (therefore lateral
forces) in between cells, ECs failed to collectively polarize toward
the wound. Under flow, every cell is independently exposed to
the same directional signal: SS at their apical side. Combining
these facts and observations allows to hypothesize that the origin
of the mechanical signal and its way of transmission in-between
cells is crucial to determine if loosening of the lateral tension
will lead to loss or reinforcement of polarity. In the case of a
wound closure, loosening junctions decreases collective polarity
toward the wound because ECs distant from the wound become
blind to its location. In our settings, loosening junctions increases
polarity against the flow because ECs become more capable of
detecting flow direction as signal from the lateral junctions does
not interfere with the apical cue each cell perceive.
Interestingly, while testing inhibitor effects on polarity and
alignment under high SS, we find that SRC family inhibition is
efficient only without VEGF-A, i.e., a situation in which ZO-1
is present at the junctions and phospho-Paxillin is low, lateral
tension should be high and basal tension low. In contrast, FAK
inhibition is efficient only with VEGF-A, a situation in which ZO-
1 is delocalized from the junctions and phospho-Paxillin is high,
suggesting low lateral tension and high basal tension. Therefore,
it is tempting to speculate that rather than having different
pathways controlling polarity and alignment independently, the
same pathways could be in charge of polarity and alignment, but
their relative contribution would vary depending on the presence
or absence of VEGF-A. SRC family members would participate
when VEGF-A is absent and FAK pathways would take over once
VEGF-A is present to loosen the junction.
Finally, modification in flow sensitivity in ECs has been
ascribed to the mechanosensitive complex formed by VEGFRs-
PECAM-VE-cadherin (Baeyens et al., 2015), and in particular to
the ratio of VEGFR3 or VEGFR2 engaged in this complex, thus
modifying at which range of SS ECs align with the flow. Here we
show that the joint presence of flow and VEGF-A can also act as
a lever to influence ECs alignment and polarity mostly through
changes in the balance of the different VEGFR2 phospho-sites
that become activated. Whether or not alignment and polarity go
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precisely through the same type of complex and if VEGFR3 could
also play a role will need to be demonstrated.
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Supplementary Figure 1 | VEGF-A treatment does not affect cell number but
increases cell elongation. (A) Quantification of endothelial cells number under flow
and VEGF-A. (B) Quantification of aspect ratio (length of main axis/length of short
axis) of endothelial cells under flow and VEGF-A. N = 3, between 1,500 and 3,000
cells analyzed. N = 3, around 1,500 cells analyzed. Data presented as
Mean + SEM. Two-way ANOVA; Tukey’s post hoc, ∗∗∗p < 0.001 compared to
static 0 VEGF; ###p < 0.001 (compared to LSS 0 VEGF); ! !!p < 0.001
(compared to HSS 0 VEGF).
Supplementary Figure 2 | VEGF treatment does not change junctions activation
under static condition. (A) Representative picture (Immunofluorescence) of
endothelial cells exposed to VEGF-A for 24 h. Red arrows indicate gaps in the
ECs monolayer (B) Quantification of junction status based on their morphology
(N = 3; 100 patches analyzed blinded by images, 5–8 images per N).
Supplementary Figure 3 | Proteins expression upon flow and VEGF treatment.
(A) VEGFR2 expression assessed by WB, N = 6. (B) ZO1 expression assessed by
WB, N = 3. (C) VE-cadherin expression assessed by WB, N = 5. (D) FAK
expression assessed by WB, N = 5. ANOVA followed by Tukey post Hoc;
∗p < 0.05; ∗∗p < 0.01. (E) Representative pictures of the quantified WB.
Supplementary Figure 4 | Inhibitors effect on cell elongation. Quantification of
aspect ratio (length of main axis/length of short axis) of endothelial cells under high
SS with or without VEGF-A (10 ng/mL) and with or without inhibitors (DMSO,
N = 5, inhibitors N = 3) One-way ANOVA; Tukey’s post hoc, ∗∗∗p < 0.001
compared to DMSO 0 VEGF; ###p < 0.001 compared to DMSO 10 VEGF.
Supplementary Figure 5 | VEGFR2 mutation impairs cell length but not SRC
deletion in vivo. (A) Quantification of ECs length in the aortas of P6 pups littermate
(CTR) or carrying VEGFR2 mutation (Y949F). N = 5 (B) Distribution of cell length.
N = 5 (C) Quantification of ECs length in the aortas of P6 pups littermate (CTR) or
deleted for SRC in ECs (SRCiEC−KO). N = 3–5 (D) Distribution of cell length.
Unpaired T-Test; ∗∗∗p < 0.001.
Supplementary Figure 6 | ECs polarity is not impaired during directional
sprouting upon loss of c-Src. Representative images and quantification of polarity
of ECs sprouting out of metatarsal ex vivo. With means that ECs polarize in the
direction of the sprout (0–30◦); side, ECs present their golgi on the side of the cell
(30–150◦); against, ECs polarize in the opposite direction of the sprout (150–180◦).
N = 294 cells analyzed from 12 metatarsals from 2 independent experiments.
Supplementary Table 1 | p-Values for each comparison for Figures 2B,D.
Two-way ANOVA; Tukey’s post hoc, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Gray
lines: statistics presented on the graphs. Bold: significant difference.
Supplementary Table 2 | p-Values for each comparison for Figures 3C–F.
Two-way ANOVA; Fisher LSD. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Gray lines:
statistics presented on the graphs. Bold: significant difference.
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